VP, Medical Affairs & Strategy — Neuroscience

Discover International; Fairmont (OK); On-site; USD 250,000 - 400,000; Full time

Benefits offered by this job

Annual bonus

Long-Term Incentives (LTI)

Comprehensive benefits

401k match

Job summary

Discover International is seeking a Vice President of Medical Affairs to lead the company's medical strategy, build and scale the Medical Affairs function, and serve as a senior scientific partner across the organization.

You will shape medical strategy and execution, cultivate KOLs, guide the field medical organization, and ensure alignment with clinical development, regulatory, and commercial priorities.

Qualifications

• MD/DO/PhD or equivalent advanced degree.
• 10+ years of Medical Affairs or related biopharma experience.
• Proven Medical Affairs leadership and team-building experience.
• Neuroscience/CNS experience strongly preferred.
• Experience in a pre-commercial or newly launched biotech preferred.
• Strong KOL relationships and executive presence.

Responsibilities

• Lead overall Medical Affairs strategy and execution.
• Build and lead the Medical Affairs and field medical organization.
• Develop KOL strategy and key external scientific relationships.
• Collaborate cross-functionally with Clinical Development, Commercial, and Regulatory.
• Translate field and external insights into clinical and evidence-generation priorities.
• Establish Medical Affairs capabilities, KPIs, and operating plans.
• Serve as a senior scientific advisor to executive leadership.

Skills

Medical Affairs leadership

KOL relationship management

Cross-functional collaboration

Strategic planning

Executive presence

Education

MD/DO/PhD or equivalent advanced degree

Job description

Discover International is seeking a Vice President of Medical Affairs to lead the company's medical strategy, build and scale the Medical Affairs function, and serve as a senior scientific partner across the organization.

You will shape medical strategy and execution, cultivate KOLs, guide the field medical organization, and ensure alignment with clinical development, regulatory, and commercial priorities.